SCTX

Conviction 0HealthcareScan · Wed, Jul 29, 2026

SCTX$18.06-4.80%

ResistanceSupportVol 14Insider buy

Jul 24Jul 27Jul 28

Scribe Therapeutics, Inc.Biological Products, (No Diagnostic Substances)

Price18.06

Change-4.80%

Gap-5.11%

Rel volume0.61×

Avg volume612.84K

Avg $ vol12.38M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrend—

RSI (14)—

MACD hist—

MACD cross—

Stoch %K / %D— / —

ADX (14)—

+DI / −DI— / —

RSI divergence—

MACD divergence—

ATR %—

ADR %—

52w high21.65

52w low18.06

From 52w high-16.58%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)—

vs AVWAP high—

AVWAP (52w low)—

vs AVWAP low—

OBV trend—

Chaikin MF (20)—

Today vs 20d0.61×

Avg vol (14d)—

Avg vol (20d)612.84K

Avg $ vol (20d)12.38M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank—

1 week—

1 month—

3 months—

6 months—

1 year—

YTD-16.58%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float1.7M

Float %10.5%

Short interest—

Days to cover—

Short volume62.8%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank—

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in SCTX

All disclosures →

No recent disclosed trades by Congress in SCTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCTX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Aghazadeh Behzad Director · Common Stock, par value $0.0001 per share · 2026-07-28	Buy	7.91K	$144K	2026-07-28	2026-07-28
Aghazadeh Behzad Director · Common Stock, par value $0.0001 per share · 2026-07-24	Buy	2.33M	$35M	2026-07-24	2026-07-28
Aghazadeh Behzad Director · Common Stock, par value $0.0001 per share · 2026-07-24	Buy	50K	$1.1M	2026-07-24	2026-07-28
Staahl Brett 10% owner · Stock Option (Right to Buy) · 2026-07-23	Grant	19.39K	—	2026-07-23	2026-07-28
Staahl Brett 10% owner · Performance-based Stock Option (Right to Buy) · 2026-07-23	Grant	19.39K	—	2026-07-23	2026-07-28
Staahl Brett 10% owner · Stock Option (Right to Buy) · 2026-03-13	Grant	4.75K	—	2026-03-13	2026-07-28
Lucas Svetlana Chief Business Officer · Performance-based Stock Option (Right to Buy) · 2026-07-23	Grant	109.43K	—	2026-07-23	2026-07-27
Watson James Dean Director · Stock Option (Right to Buy) · 2026-07-23	Grant	14.72K	—	2026-07-23	2026-07-27
Aghazadeh Behzad Director · Stock Option (Right to Buy) · 2026-07-23	Grant	14.72K	—	2026-07-23	2026-07-27
Bleharski Joshua Director · Stock Option (Right to Buy) · 2026-07-23	Grant	14.72K	—	2026-07-23	2026-07-27

SEC filings

EDGAR filings in SCTX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.